CAS 170729-80-3
:Aprepitant
Descrizione:
Aprepitant è un antagonista selettivo del recettore della neurochinina-1 (NK1), utilizzato principalmente nella prevenzione della nausea e del vomito associati alla chemioterapia e alla chirurgia. È classificato come una piccola molecola e viene spesso somministrato per via orale. Aprepitant mostra un'alta affinità per il recettore NK1, che gioca un ruolo cruciale nella risposta emetica mediata dalla sostanza P, un neuropeptide coinvolto nella percezione del dolore e nell'infiammazione. La sostanza è caratterizzata dalla sua relativamente bassa solubilità in acqua, che influisce sulla sua formulazione e biodisponibilità. Aprepitant è tipicamente utilizzato in combinazione con altri agenti antiemetici per migliorare l'efficacia terapeutica. La sua farmacocinetica prevede un ampio metabolismo nel fegato, principalmente attraverso il sistema del citocromo P450, portando a potenziali interazioni farmacologiche. Gli effetti collaterali comuni possono includere affaticamento, vertigini e disturbi gastrointestinali. In generale, Aprepitant rappresenta un significativo progresso nella gestione della nausea e del vomito indotti dalla chemioterapia, migliorando la qualità della vita dei pazienti sottoposti a trattamento per il cancro.
Formula:C23H21F7N4O3
InChI:InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
InChI key:InChIKey=ATALOFNDEOCMKK-OITMNORJSA-N
SMILES:C(N1[C@H]([C@@H](O[C@H](C)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)OCC1)C3=CC=C(F)C=C3)C4=NNC(=O)N4
Sinonimi:- 3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-
- 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, [2R-[2α(R*),3α]]-
- 5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one, Emend
- 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one
- Emend
- L 754030
- Mk 869
- Mk-0869
- Vedi altri sinonimi
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
17 prodotti.
Aprepitant
CAS:Formula:C23H21F7N4O3Purezza:>98.0%(HPLC)Colore e forma:White to Almost white powder to crystalPeso molecolare:534.43Aprepitant
CAS:AprepitantFormula:C23H21F7N4O3Purezza:99.9%Colore e forma:White. To. BeigePeso molecolare:534.15019Aprepitant
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H21F7N4O3Colore e forma:White Off-White PowderPeso molecolare:534.150195-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one
CAS:Formula:C23H21F7N4O3Purezza:98%Colore e forma:SolidPeso molecolare:534.4267Ref: IN-DA0034H4
1g68,00€5g137,00€1kgPrezzo su richiesta25g308,00€5mg26,00€250gPrezzo su richiesta25mg30,00€500gPrezzo su richiesta50mg31,00€250mg31,00€500mg50,00€Aprepitant
CAS:Formula:C23H21F7N4O3Purezza:(HPLC) ≥ 98.0%Colore e forma:White to off-white powderPeso molecolare:534.43Aprepitant Impurity 31
CAS:Formula:C27H24F7NO2Colore e forma:White To Off-White SolidPeso molecolare:527.49Aprepitant
CAS:<p>Aprepitant (Aprepitant`) is a Substance P/Neurokinin-1 Receptor Antagonist.</p>Formula:C23H21F7N4O3Purezza:98% - 99.68%Colore e forma:Off-White To Light Yellow Cyrstalline SolidPeso molecolare:534.43Aprepitant
CAS:Prodotto controllato<p>Applications Aprepitant is a neurokinin-1 antagonist and an antiemetic agent (1). It is used to prevent chemotherapy-induced nausea and vomiting (CINV) in colorectal cancer patients (2) Aprepitant has also been shown to induce apoptotic cell death and G1 arrest through Akt/p53 axis in pre-B acute lymphoblastic leukemia cells (3).<br>References (1) Takemoto, H., et al.: nt J Clin Oncol (2016) (2) Bayati, S., et al.: Eur J Pharmacol. 791, 274 (2016) (3) Navari, R.M.: Expert Rev Anticancer Ther. 4, 715 (2004)<br></p>Formula:C23H21F7N4O3Colore e forma:Off-WhitePeso molecolare:534.43Aprepitant
CAS:<p>Aprepitant is a neurokinin-1 receptor antagonist. It is an antiemetic which suppresses nausea and vomiting and has proven to be especially useful alongside cancer chemotherapy and as a tool in cancer-related studies. Aprepitant binds to the neurokinin-1 receptor in the brain, preventing it from binding to substance P. This prevents substance P from stimulating nerves in the vomiting center of the brain, reducing feelings of nausea and vomiting. Aprepitant has been shown to be effective against HIV infection, with no major side effects. The use of aprepitant for HIV therapy may be limited due to its ability to cause serious liver damage when taken with other drugs that are metabolized by cytochrome P450 enzymes.</p>Formula:C23H21F7N4O3Purezza:Min. 98%Colore e forma:White Off-White PowderPeso molecolare:534.43 g/molAprepitant - Bio-X ™
CAS:<p>Aprepitant is a neurokinin-1 receptor antagonist. It is an antiemetic which suppresses nausea and vomiting and has proven to be especially useful alongside cancer chemotherapy and as a tool in cancer-related studies. Aprepitant binds to the neurokinin-1 receptor in the brain, preventing it from binding to substance P. This prevents substance P from stimulating nerves in the vomiting center of the brain, reducing feelings of nausea and vomiting. Aprepitant has been shown to be effective against HIV infection, with no major side effects. The use of aprepitant for HIV therapy may be limited due to its ability to cause serious liver damage when taken with other drugs that are metabolized by cytochrome P450 enzymes.</p>Formula:C23H21F7N4O3Purezza:Min. 98 Area-%Peso molecolare:534.43 g/molRef: ST-EA-CP-F36003
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta













